- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
-
Mabuchi S, Sugiyama T, Kimura T
- KMID: 2363325
- J Gynecol Oncol.
- 2016 May;27(3):e31.
- doi: 10.3802/jgo.2016.27.e31
Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Feature of amenorrhea in postoperative tamoxifen users with breast cancer
-
Kim H, Han W, Ku SY, Suh CS, Kim SH, Choi YM
- KMID: 2413453
- J Gynecol Oncol.
- 2017 Mar;28(2):e10.
- doi: 10.3802/jgo.2017.28.e10
OBJECTIVE: Tamoxifen has been used to prevent the recurrence of breast cancer. However, tamoxifen-users frequently experience amenorrhea and it can be confused from that caused by other hormonal abnormalities. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Carcinoma of the cervix in elderly patients treated with radiotherapy: patterns of care and treatment outcomes
-
Lin MY, Kondalsamy-Chennakesavan S, Bernshaw D, Khaw P, Narayan K
- KMID: 2374261
- J Gynecol Oncol.
- 2016 Nov;27(6):e59.
- doi: 10.3802/jgo.2016.27.e59
OBJECTIVE: The aim of this analysis was to examine the management of cervix cancer in elderly patients referred for radiotherapy and the results of treatment in terms of overall survival... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08)
-
Cha J, Kim YS, Park W, Kim HJ, Kim JY, Kim JH, Kim J, Yoon WS, Kim JW, Kim YB
- KMID: 2374260
- J Gynecol Oncol.
- 2016 Nov;27(6):e58.
- doi: 10.3802/jgo.2016.27.e58
OBJECTIVE: To investigate the role of radiotherapy (RT) in patients who underwent hysterectomy for uterine carcinosarcoma (UCS). METHODS: Patients with the International Federation of Gynecology and Obstetrics stage I–IVa UCS who... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
-
Ikeda Y, Furusawa A, Kitagawa R, Tokinaga A, Ito F, Ukita M, Nomura H, Yamagami W, Tanabe H, Mikami M, Takeshima , Yaegashi N
- KMID: 2363323
- J Gynecol Oncol.
- 2016 May;27(3):e29.
- doi: 10.3802/jgo.2016.27.e29
OBJECTIVE: Although radiation therapy (RT) and concurrent chemoradiotherapy (CCRT) are the global standards for adjuvant therapy treatment in cervical cancer, many Japanese institutions choose chemotherapy (CT) because of the low... -
- CITED
-
- Close
- SHARE
-
- Close
